MetaQuotes stops selling MT4 platform licenses

Forex trading platform developer MetaQuotes just announced that it has stopped selling MetaTrader 4 platform licenses to new customers.

The MetaTrader 4 trading platform was released more than 12 years ago. Its architecture was designed under the limitations of that time, due to which it is no longer possible to implement new features that meet today’s increased requirements of the industry, including brokers’ and traders’ demands.

MetaQuotes ended the development of MetaTrader 4 in early 2015. Now, three years later, the developer decided to discontinue the sales of this software and has stopped selling MetaTrader 4 platform licenses to new customers, including additional servers to existing clients. However, MetaTrader 4 brokers will be able to order additional White Label terminals and receive comprehensive technical support. MetaQuotes will also keep releasing security updates and bug fixes for the said platform.

Additional functions and improvements will only be implemented in MetaTrader 5. The new-generation platform is based on modern architecture and fully supports various functions from the older version (such as hedging and reports on positions). MetaTrader 5 is a high-performance scalable platform which supports operation on multiple markets, including Forex, CFDs, stocks, futures, metals and cryptocurrencies. A large-scale infrastructure comprising of third-party solutions has already formed around MetaTrader 5. Technology companies, such as FortexGold-i, oneZero, PrimeXM and Tools For Brokers among others, have adapted their products to MetaTrader 5 and offer various solutions to help brokers with migrating to the new platform.

Synthetic symbols and support for Anti-DDoS providers have been recently added to MetaTrader 5. More important updates featuring fundamentally new opportunities for brokers will be available soon. Having all of the above in mind, MetaQuaotes has decided to stop offering the outdated platform, which cannot be any further developed.

Read Also: